Results 91 to 100 of about 663,256 (217)

Overall Survival Versus Progression-Free Survival in Oncology Clinical Trials [PDF]

Value in Health, 2016
A Aissaoui, A Bin Sawad, F Turkistani, N Aissaoui   +3 more
openaire   +1 more source

RBTT-04. DOES EXERCISE IMPROVE PROGRESSION FREE SURVIVAL AND QUALITY OF LIFE IN PATIENTS WITH GLIOBLASTOMA? A TRIAL IN PROGRESS [PDF]

, 2018
Kim Edelstein, Kristin L. Campbell, Lori J. Bernstein, Ilyse Lax, Felicity Backhouse, Gregory R. Pond, Navya Kalidindi, Rosemarylin Or, Normand Laperrière, Barbara‐Ann Millar, David Shultz, Alejandro Berlín, Gelareh Zadeh, Catherine Maurice, Warren Mason   +14 more
openalex   +1 more source

P951: IMPACT OF MEASURABLE RESIDUAL DISEASE (MRD) DIFFERENCES ON PROGRESSION-FREE SURVIVAL (PFS): AN AGGREGATE DATA ANALYSIS FROM RANDOMIZED CLINICAL TRIALS IN MULTIPLE MYELOMA (MM)

, 2023
Bruno Paiva, Anastasiia Zherniakova, Jorge Núñez, Paula Rodríguez‐Otero, Qian Shi, Nikhil C. Munshi, Brian G.M. Durie, Jesús F. San Miguel   +7 more
openalex   +1 more source

Supplementary Figure 4 from Hsa-miR-31-3p Expression Is Linked to Progression-free Survival in Patients with KRAS Wild-type Metastatic Colorectal Cancer Treated with Anti-EGFR Therapy [PDF]

, 2023
Gilles Manceau, Sandrine Imbeaud, Raphaële Thiébaut, François Liébaert, Karine Fontaine, Francis Rousseau, Bérengère Génin, Delphine Le Corre, Audrey Didelot, Marc Vincent, Jean‐Baptiste Bachet, Benoist Chibaudel, Olivier Bouché, Bruno Landi, Frédéric Bibeau, Karen Leroy, Frédérique Penault‐Llorca, Jean–Luc Van Laethem, Pieter Demetter, Sabine Tejpar, Simona Rossi, Neda Mosakhani, Pia Österlund, Raija Ristamäki, Virinder Kaur Sarhadi, Sakari Knuutila, Valérie Boige, Thierry André, Pierre Laurent‐Puig   +28 more
openalex   +1 more source

Comparison of disease free survival in breast cancer molecular subtypes [PDF]

Caspian Journal of Internal Medicine
Background: Breast cancer management depends on molecular subtypes. The aim was to compare disease-free survival (DFS) among the different subgroups. Overall survival (OS) is a secondary endpoint.
Maryam Esmati, Fatemeh Monfaredi, Mohsen Vakili Sadeghi, Mohammad Ranaee, Hossein ghorbani, Sadegh Sedaghat, Hemmat Gholinia   +6 more
doaj  

Olaparib shows significant progression-free survival benefit in phase III SOLO2 trial

, 2017
Christian Marth
openalex   +2 more sources

Deepening responses associated with improved progression-free survival with ixazomib versus placebo as posttransplant maintenance in multiple myeloma [PDF]

, 2020
Hartmut Goldschmidt, Meletios Α. Dimopoulos, S. Vincent Rajkumar, Katja Weisel, Philippe Moreau, Wee Joo Chng, Gábor Mikala, Michèle Cavo, Karthik Ramasamy, Kaveri Suryanarayan, Zhaoyang Teng, Richard Labotka, María‐Victoria Mateos   +12 more
openalex   +1 more source

VP5-2022: Updated progression-free survival (PFS) and depth of response in IKEMA, a randomized phase III trial of isatuximab, carfilzomib and dexamethasone (Isa-Kd) vs Kd in relapsed multiple myeloma (MM) [PDF]

, 2022
P. Moreau, M.A.C. Dimopoulos, Joseph Mıkhael, Kwee Yong, Marcelo Capra, Thierry Façon, Roman Hájek, Ivan Špıčka, F. Casca, Sandrine Macé, Erwin Singh, M-L. Risse, Thomas G. Martin   +12 more
openalex   +1 more source

The usefulness of progression-free survival in surgical treatment of lung metastases

Polish Journal of Thoracic and Cardiovascular Surgery, 2022
Jarosław Religioni, Daniel Rabczenko, Tadeusz Orłowski   +2 more
doaj   +1 more source

Salvage Therapy of Gemcitabine Plus Endostar Significantly Improves Progression-free Survival (PFS) with Platinum-resistant Recurrent Epithelial Ovarian Cancer

, 2013
An Ping Su, Jing Zhang, Zhiren Pan, Qiming Zhou, Xia Lv   +4 more
openalex   +2 more sources